Maky Zanganeh - Net Worth and Insider Trading

Maky Zanganeh Net Worth

The estimated net worth of Maky Zanganeh is at least $130 Million dollars as of 2024-05-09. Maky Zanganeh is the CEO of Summit Therapeutics Inc and owns about 25,494,614 shares of Summit Therapeutics Inc (SMMT) stock worth over $126 Million. Maky Zanganeh is also the Director of Pulse Biosciences Inc and owns about 500,267 shares of Pulse Biosciences Inc (PLSE) stock worth over $3 Million. Details can be seen in Maky Zanganeh's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Maky Zanganeh has not made any transactions after 2024-03-27 and currently still holds the listed stock(s).

Transaction Summary of Maky Zanganeh

To

Maky Zanganeh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Maky Zanganeh owns 2 companies in total, including Pulse Biosciences Inc (PLSE) , and Summit Therapeutics Inc (SMMT) .

Click here to see the complete history of Maky Zanganeh’s form 4 insider trades.

Insider Ownership Summary of Maky Zanganeh

Ticker Comapny Transaction Date Type of Owner
PLSE Pulse Biosciences Inc 2022-05-19 director
SMMT Summit Therapeutics Inc 2024-03-27 director

Maky Zanganeh Latest Holdings Summary

Maky Zanganeh currently owns a total of 2 stocks. Among these stocks, Maky Zanganeh owns 25,494,614 shares of Summit Therapeutics Inc (SMMT) as of March 27, 2024, with a value of $126 Million and a weighting of 97.34%. Maky Zanganeh also owns 500,267 shares of Pulse Biosciences Inc (PLSE) as of June 23, 2020, with a value of $3 Million and a weighting of 2.66%.

Latest Holdings of Maky Zanganeh

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SMMT Summit Therapeutics Inc 2024-03-27 25,494,614 4.96 126,453,285
PLSE Pulse Biosciences Inc 2020-06-23 500,267 6.90 3,451,842

Holding Weightings of Maky Zanganeh


Maky Zanganeh Form 4 Trading Tracker

According to the SEC Form 4 filings, Maky Zanganeh has made a total of 5 transactions in Summit Therapeutics Inc (SMMT) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Summit Therapeutics Inc is the acquisition of 110,321 shares on March 27, 2024, which cost Maky Zanganeh around $411,497.

According to the SEC Form 4 filings, Maky Zanganeh has made a total of 2 transactions in Pulse Biosciences Inc (PLSE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Pulse Biosciences Inc is the acquisition of 1,193 shares on June 23, 2020, which cost Maky Zanganeh around $12,765.

Insider Trading History of Maky Zanganeh

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Maky Zanganeh Trading Performance

GuruFocus tracks the stock performance after each of Maky Zanganeh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Maky Zanganeh is 26.85%. GuruFocus also compares Maky Zanganeh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Maky Zanganeh within 3 months outperforms 8 times out of 13 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Maky Zanganeh's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Maky Zanganeh

Average Return

Average return per transaction

Outperforming Transactions

6 out of 12 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 19.15
Relative Return to S&P 500(%) 17.97

Maky Zanganeh Ownership Network

Ownership Network List of Maky Zanganeh

No Data

Ownership Network Relation of Maky Zanganeh


Maky Zanganeh Owned Company Details

What does Pulse Biosciences Inc do?

Who are the key executives at Pulse Biosciences Inc?

Maky Zanganeh is the director of Pulse Biosciences Inc. Other key executives at Pulse Biosciences Inc include director & 10 percent owner Robert W Duggan , Chief Commercial Officer Kevin Patrick Danahy , and CFO & EVP Admin. and Finance Sandra A. Gardiner .

Pulse Biosciences Inc (PLSE) Insider Trades Summary

Over the past 18 months, Maky Zanganeh made no insider transaction in Pulse Biosciences Inc (PLSE). Other recent insider transactions involving Pulse Biosciences Inc (PLSE) include a net purchase of 11,060,178 shares made by Robert W Duggan , a net purchase of 17,800 shares made by Mitchell E. Levinson , and a net purchase of 5,393 shares made by Kevin Patrick Danahy .

In summary, during the past 3 months, insiders sold 0 shares of Pulse Biosciences Inc (PLSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulse Biosciences Inc (PLSE) were sold and 11,083,371 shares were bought by its insiders, resulting in a net purchase of 11,083,371 shares.

Pulse Biosciences Inc (PLSE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pulse Biosciences Inc Insider Transactions

No Available Data

Maky Zanganeh Mailing Address

Above is the net worth, insider trading, and ownership report for Maky Zanganeh. You might contact Maky Zanganeh via mailing address: 51 Adam Way, Atherton Ca 94027.

Discussions on Maky Zanganeh

No discussions yet.